Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition

A G S Buggins, C Pepper, C H Jones, E J Walsby, F Forconi, G Pratt, S Devereux, F. K. Stevenson, C Fegan

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)
158 Downloads (Pure)
Original languageEnglish
Pages (from-to)744-747
Number of pages4
JournalLeukemia
Volume29
Issue number3
DOIs
Publication statusPublished - 29 Mar 2015

Cite this